Acknowledgement
Grant : Development of Exploring Support System on Global Future Technologies, Development of emergence indicators based on journal.patent growth pattern analysis
Supported by : Korea Institute for Science and Technology Information, Ministry of Science, ICT and Future Planning
References
- Moses JW, Leon MB, Popma JJ, Fitzerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE: Silorimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349(14):1315-1323. https://doi.org/10.1056/NEJMoa035071
- Morice MC, Serruyys PW, Sousa JE, Fajadet J, Ban HE, Perrin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002, 346(23):1773-1780. https://doi.org/10.1056/NEJMoa012843
- Bengisu M, Nekhili R: Forecasting emerging technologies with the aid of science and technology databases. Technol Forecast Soc Change 2006, 73:835-844. https://doi.org/10.1016/j.techfore.2005.09.001
- Ryu JY: Dynamic Technology Level Evaluation Methodology and Forecasting based on Technology Growth Curve, Ph. D Thesis. KAIST; 2012.
- Lee HJ, Kang JS, Goh BY: Bibliometric Indicators to identify Core Research Institutions in Green Technology (Dye-Sensitized Solar Cell). In Proceeding of Convergence Technology & Information Convergence; 2009:95-102.
- Van Eck NJ, Waltman L: Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010, 84(2):523-538. https://doi.org/10.1007/s11192-009-0146-3
- Kim SJ, Park J-G, Kim JH, Kown IK: An overview of researches trend in drug-eluting stents development. Biomater Res 2010, 14(1):37-49.
- Kim SH, Hong MK: Current status of drug-eluting stents. Korean J Med 2008, 75:370-382.
- Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM: Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007, 297(2):159-168. https://doi.org/10.1001/jama.297.2.joc60179
- Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Halffner SM, Hamm CW, Hankey GJ, Johnston SC, Mark KH, Mas JL, Montalescot G, Pearson TA, Steinhubl PG, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, 354(16):1706-1717. https://doi.org/10.1056/NEJMoa060989
Cited by
- Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co–Cr substrates for prevention of initial in-stent restenosis vol.140, pp.None, 2016, https://doi.org/10.1016/j.colsurfb.2016.01.009
- Surface heparinization and blood compatibility modification of small intestinal submucosa (SIS) for small-caliber vascular regeneration vol.28, pp.3, 2017, https://doi.org/10.3233/bme-171668